Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ma Victoria Mateos"'
Autor:
Philippe Moreau, Pieter Sonneveld, Mario Boccadoro, Gordon Cook, Ma Victoria Mateos, Hareth Nahi, Hartmut Goldschmidt, Meletios A. Dimopoulos, Paulo Lucio, Joan Bladé, Michel Delforge, Roman Hajek, Heinz Ludwig, Thierry Facon, Jesus F. San Miguel, Hermann Einsele
Publikováno v:
Haematologica, Vol 104, Iss 12 (2019)
Adoptive cellular therapy using chimeric antigen receptor T-cell (CART) therapy is currently being evaluated in patients with relapsed / refractory multiple myeloma (MM). The majority of CAR-T cell programs now being tested in clinical trials are tar
Externí odkaz:
https://doaj.org/article/832959da49bd439dbd6340d7e347a6f4
Autor:
Pieter Sonneveld, Jesús F. San Miguel, Roman Hájek, Philippe Moreau, Mario Boccadoro, Michel Delforge, Hartmut Goldschmidt, Hermann Einsele, Hareth Nahi, Joan Bladé, Thierry Facon, Paulo Sérgio Lucio, Heinz Ludwig, Ma Victoria Mateos, Gordon Cook, Meletios A. Dimopoulos
Publikováno v:
Haematologica
Haematologica, 104(12), 2358-2360. Ferrata Storti Foundation
Haematologica, 104(12), 2358-2360. Ferrata Storti Foundation
Adoptive cellular therapy using chimeric antigen receptor T-cell (CART) therapy is currently being evaluated in patients with relapsed / refractory multiple myeloma (MM). The majority of CAR-T cell programs now being tested in clinical trials are tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caebab00a438d4573646a0bc4e77dbe
https://doi.org/10.3324/haematol.2019.224204
https://doi.org/10.3324/haematol.2019.224204
Autor:
Enrique M. Ocio, Pedro Mogollón, Mercedes Garayoa, Laura San Segundo, Lorena González-Méndez, Teresa Paíno, Andrea Diaz, Patryk Krzemiński, Susana Hernández-García, Luis Cochete, Mª-Victoria Mateos, Laura Nevola, Norma C. Gutiérrez, Macarena Algarín, Montserrat Martín-Sánchez, Santiago Esteban
Publikováno v:
Cancer Research. 81:1291-1291
Multiple myeloma (MM) is a blood malignancy having its origin in differentiated B cells.1 The overall survival of MM patients has clearly improved with the use of autologous stem cell transplantation and the more recent introduction of novel therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43c25e5d17dd3cec2095289f7248d6aa
https://doi.org/10.1158/1538-7445.am2021-1291
https://doi.org/10.1158/1538-7445.am2021-1291
Autor:
Norma C. Gutiérrez, Jose Francisco Tomas, Ma Jesús Blanchard, Isabel Krsnik, Ma Victoria Mateos, Juan José Lahuerta, Belén Iñigo, Jesús F. San Miguel, Laura Rosiñol, Miguel T. Hernandez, Luis Palomera, Ana Isabel Teruel, Javier de la Rubia, Raquel Jiménez-Segura, Dolores Hernández, Joan Bladé
Publikováno v:
Blood. 122:3188-3188
Introduction In April 2006, the Spanish Myeloma Group (PETHEMA/GEM) initiated a randomized phase III trial (GEM05menos65) comparing induction with thalidomide/dexamethasone (TD) vs. bortezomiv/thalidomide/dexamethasone (VTD) vs. VBMCP/VBAD/Bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c721aff749c195feb5f33ef38362db65
https://doi.org/10.1182/blood.v122.21.3188.3188
https://doi.org/10.1182/blood.v122.21.3188.3188
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johan Vansteenkiste, Jean-Luc Canon, Irene Ferreira, Tom Lillie, Ma Victoria Mateos, Laurent Bastit, György Bodoky
Publikováno v:
Blood. 106:3558-3558
Background: Darbepoetin alfa (Aranesp®; DA) is an erythropoiesis-stimulating protein (ESP) effective for treating chemotherapy-induced anemia (CIA). Every-3-week (Q3W) administration has been shown to be effective in treating CIA in a randomized, do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae738530472229cc1458a9c2a155037c
https://doi.org/10.1182/blood.v106.11.3558.3558
https://doi.org/10.1182/blood.v106.11.3558.3558
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.